UniSa - IRIS Institutional Research Information System

PERSICO, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.067
NA - Nord America 10.890
EU - Europa 4.181
SA - Sud America 990
AF - Africa 169
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 31.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.645
HK - Hong Kong 9.755
SG - Singapore 2.402
IT - Italia 1.573
CN - Cina 1.195
BR - Brasile 752
VN - Vietnam 705
UA - Ucraina 645
RU - Federazione Russa 431
DE - Germania 352
FR - Francia 251
IE - Irlanda 245
KR - Corea 231
FI - Finlandia 176
TR - Turchia 173
SE - Svezia 132
CA - Canada 131
GB - Regno Unito 112
IN - India 111
BD - Bangladesh 109
AR - Argentina 91
JP - Giappone 80
MX - Messico 64
ZA - Sudafrica 56
IQ - Iraq 49
NL - Olanda 41
ES - Italia 40
ID - Indonesia 40
EC - Ecuador 39
AT - Austria 33
PL - Polonia 32
VE - Venezuela 31
CO - Colombia 30
PK - Pakistan 28
DK - Danimarca 27
SA - Arabia Saudita 20
MA - Marocco 18
MY - Malesia 18
EG - Egitto 17
UZ - Uzbekistan 17
PY - Paraguay 16
AU - Australia 15
TW - Taiwan 15
PH - Filippine 14
AZ - Azerbaigian 12
DZ - Algeria 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JO - Giordania 11
LT - Lituania 11
RO - Romania 11
TN - Tunisia 11
IL - Israele 10
PE - Perù 10
AL - Albania 9
CL - Cile 9
CR - Costa Rica 9
KE - Kenya 9
GT - Guatemala 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
GR - Grecia 7
HN - Honduras 7
OM - Oman 7
PT - Portogallo 7
SN - Senegal 7
BE - Belgio 6
EU - Europa 6
BO - Bolivia 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
NO - Norvegia 5
UG - Uganda 5
BH - Bahrain 4
CG - Congo 4
LB - Libano 4
NP - Nepal 4
NZ - Nuova Zelanda 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
BS - Bahamas 3
CI - Costa d'Avorio 3
ET - Etiopia 3
GY - Guiana 3
IR - Iran 3
LY - Libia 3
ME - Montenegro 3
MW - Malawi 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
SC - Seychelles 3
AF - Afghanistan, Repubblica islamica di 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
BN - Brunei Darussalam 2
BW - Botswana 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 31.289
Salva come PNG Salva come JPEG
Città #
Hong Kong 9.707
Ann Arbor 1.681
Singapore 1.239
San Jose 1.078
Chandler 838
Jacksonville 820
Princeton 723
Milan 596
Ashburn 545
Woodbridge 520
Dallas 457
Wilmington 366
Houston 305
Beijing 269
Council Bluffs 255
The Dalles 254
Dublin 238
Dong Ket 217
Lauterbourg 204
Andover 164
Ho Chi Minh City 163
Rome 152
Nanjing 147
Izmir 143
Los Angeles 128
Pellezzano 128
Boardman 123
Hanoi 109
Moscow 95
New York 87
Santa Clara 86
Munich 75
Naples 74
Memphis 68
Salerno 66
São Paulo 66
Tokyo 62
Hebei 55
Shenyang 54
Ottawa 47
Changsha 45
Fairfield 45
Figino 44
Columbus 43
Norwalk 43
Nanchang 42
Brooklyn 39
Jiaxing 39
Montreal 39
Turin 37
Frankfurt am Main 34
Düsseldorf 33
Redwood City 33
Nuremberg 31
Denver 30
Johannesburg 30
Stockholm 30
Tianjin 29
Chennai 28
Jinan 28
Orem 26
Rio de Janeiro 26
Turku 26
Washington 26
London 25
Mestre 25
Mexico City 25
Haiphong 24
Seattle 24
Warsaw 24
Chicago 23
Da Nang 23
Belo Horizonte 22
Phoenix 22
Atlanta 21
Boston 21
Guangzhou 21
Amsterdam 20
Dhaka 20
Falls Church 20
Dearborn 19
Brasília 18
San Diego 18
Curitiba 17
Helsinki 17
Baghdad 16
Tashkent 15
Vienna 15
Caracas 14
Manchester 14
Guayaquil 13
Lappeenranta 13
Nürnberg 13
San Francisco 13
Shanghai 13
Toronto 13
Biên Hòa 12
Cambridge 12
Poplar 12
Pune 12
Totale 23.879
Salva come PNG Salva come JPEG
Nome #
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project) 965
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 768
Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study 765
Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series 713
Non Alcoholic Fatty Liver: Epidemiology and Natural History 628
Impact of telaprevir in HCV patients with cirrhosis and RVR: Real-life data from boceprevir or telaprevir based “triple therapy” experience in southern Italy 609
Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control 576
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 518
Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects. 505
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 441
Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. 413
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL Study 397
Prospective validation of the CLIP score: a new prognostic system for patient with cirrhosis and hepatocellular carcinoma 390
Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program 380
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 370
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma. 347
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 322
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 321
The influence of acute lifestyle changes on NAFLD evolution in a multicentre cohort: a matter of body composition 317
442 TNF-alpha and IL-10 genetic polymorphisms influence the natural history and the response to antiviral therapy in HCV related chronic hepatitis 312
Alcoholic Hepatitis: Pathogenesis, Diagnosis and Treatment 303
18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of early response in a primary hepatic lymphoma 297
A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C. 293
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 280
"Non alcoholic fatty liver disease and eNOS dysfunction in humans" 264
Efficacy and safety of new direct antiviral agents in HCV infected patients with Diffuse Large B Cell Non-Hodgkin Lymphoma 209
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 192
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 192
The diagnostic conundrum in non-alcoholic fatty liver disease 189
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 187
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 183
Non-ulcer dyspepsia and Helicobacter pylori in type 2 diabetic patients: association with autonomic neuropathy. 180
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. 158
Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3 158
[629] THE INFLUENCE OF OBESITY AND DIABETES ON CLINICAL AND THERAPEUTICAL OUTCOME IN HCV RELATED CHRONIC HEPATITIS: AN ITALIAN NATIONWIDE SURVEY STUDY (PROBE GROUP) 154
Coeliac disease and C virus-related chronic hepatitis: a non association 153
Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis 153
HIGH PREVALENCE OF HEPATITIS C (HCV) INFECTION AND FAVORABLE PROGNOSIS IN PRIMARY HEPATIC LYMPHOMA (PHL) 151
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection 150
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach]. 147
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 147
Timed regulation of P-Element-Induced Wimpy Testis-interacting RNA expression during rat liver regeneration. 146
Alcoholic Liver Disease and Hepatitis C Chronic Infection 144
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon. 144
Epidemiology and Natural History of Alcoholic Liver Disease 143
Adiponectin in hepatology 143
Pharmacotherapy of alcoholic liver disease in clinical practice 142
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 141
The role of fructose in non-alcoholic steatohepatitis: Old relationship and new insights 133
The effect of antiviral therapy on hepatitis C virus-related thrombocytopenia: a case report. 132
507 The role of HBV occult infection in patients with non-hodgkin lymphoma: Prevalence and treatment options with nucleotide analogues 132
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 132
Age-associated decline of hepatic handling of cholephilic anions in humans is reverted by S-adenosylmethionine (SAMe). 131
A controlled trial on treatment of patients with HCV infection and abnormal liver function tests with or without liver biopsy 131
A 15-Yr Prospective Histological Follow-Up Study in Patients With Persistently Normal Aminotransferase Levels (PNAL) Carrying HCV Infection. 130
[Diabetic neuropathies. IV. Autonomous neuropathy. Peripheral sympathetic innervation and the cardiovascular system]. 130
Ultrasound-guided fine needle aspiration biopsy of portal vein thrombosis in liver cirrhosis: results in 15 patients. 130
Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. 130
Antiviral therapy: Why does it fail in HCV-related chronic hepatitis? 129
154 LOW RATE OF ONE-YEAR MORTALITY IN PATIENTS WITH STAGE 4 CIRRHOSIS: THE ITALIAN ASSOCIATION FOR THE STUDY OF LIVER (A.I.S.F.)-EPASCO PROSPECTIVE MULTICENTRE STUDY 128
Vascular endothelial dysfunction in inflammatory bowel diseases: Pharmacological and nonpharmacological targets 126
Screening, Linkage to Care and Treatment of Hepatitis C Infection in Primary Care Setting in the South of Italy 126
Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma. 125
Risk factors for hospital readmission of elderly patients. 124
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 124
A randomised controlled trial on pegylated interferon alfa-2a (40kd)(Pegasys) or IFN alfa-2a (ROFERON-A) plus ribavrin (RBV) and amantadine (AMA) vs IFN alfa-2a and RBV in naïve patients with chronic HCV 123
Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients 122
Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea 122
93 HCV genotype 2 and 3 can be cured by PEG-IFN-alfa-2B and RBV for 12 wks: A randomized controlled study 121
Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in HCV infected patients with chronic kidney disease 121
Electrophysiological evidence for Na+-coupled bicarbonate transport in cultured rat hepatocytes 120
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 119
Corrigendum to "Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma" [J Hepatol 49 (2008) 557-563] (DOI:10.1016/j.jhep.2008.06.025) 119
Controversies about the histological features of chronic HCV patients with persistently normal alanine transaminase levels: what can be done about the present definition? 118
The aetiology of chronic hepatitis in Italy: results from a multicentre national study 118
Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. 116
A 3-ARM randomized study evaluating the efficacy of triple therapy of pegylated or recombinant interferon alpha-2a 3 MU both combined with ribavirin and amantadine versus dual therapy of recombinant interferon alpha-2a plus ribavirin in naive patients with chronic HCV hepatitis 116
478 Treating chronic hepatitis C in daily practice with PEG-IFN alfa2B and ribavirin. An Italian multicentre study 116
Impact of telaprevir in HCV patients with cirrhosis and RVR: real-life data from Boceprevir or Telaprevir based "triple therapy" experience in southern Italy 114
Steatosis as a co-factor in chronic liver diseases 113
Viral hepatitis: Milestones, unresolved issues, and future goals 113
Na+-H+ exchange activity in rat hepatocytes: Role in regulation of intracellular pH 111
Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C 111
HCV antiviral therapy in injection drug users: difficult to treat or easy to cure? 111
Hepatitis C screening during SARS-CoV-2 testing or vaccination. Experience in an area of Southern Italy in the province of Salerno 111
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system]. 110
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study. 110
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease 109
Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells 109
Abnormal hepatic uptake of low doses of sulfobromophthalein in Gilbert's syndrome: the role of reduced affinity of the plasma membrane carrier of organic anions. 108
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 106
Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment 106
Metabolic associated steatotic liver disease in renal transplant recipients: a retrospective cohort study 105
Familial clustering of heterogeneous chronic unconjugated hyperbilirubinemia. 105
Etiology of newly-diagnosed cases of chronic liver disease in Southern Italy: Results of a prospective multicentric study 105
Evaluation of allelic frequency and genetic risk score of non-alcoholic fatty liver disease in a population of Southern Italy 104
Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. 103
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study. 103
Interference of diet on liver histology and on the response to interferon therapy in patients with HCV-related chronic liver disease 103
Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease 103
Totale 21.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.248 6 3 8 6 26 24 34 58 193 169 156 565
2022/20232.009 207 118 63 237 291 430 12 185 301 5 108 52
2023/2024890 82 120 69 32 71 140 32 44 8 34 51 207
2024/20252.756 73 46 56 118 152 290 434 323 486 170 291 317
2025/202618.202 1.663 4.630 4.623 550 1.186 593 1.750 346 548 911 302 1.100
2026/2027143 143 0 0 0 0 0 0 0 0 0 0 0
Totale 31.708